Equity Brief · Basic Materials2026-05-20
CTVA·Basic Materials

Corteva Inc

I · AI Analysis

The brief

Corteva develops and sells advanced seeds with built-in traits (drought tolerance, pest resistance) and crop protection products (herbicides, insecticides, nitrogen stabilizers) that help farmers maximize yield and manage pests [Corteva.com]. The company also offers digital tools to assist farmers in selecting the right products and optimizing field-level decisions [Corteva.com].

Corteva is a U.S.-based agriculture company that sells seeds (with traits for pest and weather resistance) and crop protection chemicals (herbicides, insecticides) to farmers globally [Corteva.com]. The company generated $17.4B in revenue over the last twelve months with solid free cash flow of $2.8B, though its PE ratio of 43.8x is elevated relative to modest 2.9% revenue growth [Yahoo Finance]. Insider Brian Titus sold $636K in February 2026, while several major institutions significantly increased their stakes in the most recent quarter [SEC Form 4, EODHD].

Corteva is financially stable with strong cash generation and low debt, though profitability metrics are modest for a company trading at 43.8x earnings [Yahoo Finance].

The brief AI analysisConfidence 7/10

Sentinellis health

6.3/10

Moderate concerns

Market capitalisation

$54.2B

Revenue (TTM)

$17.4B

Explainers

How we read these numbers

Plain-English guides · no account needed

Premium · Free with any account

Corteva trades at a PE ratio of 43.8x while growing revenue at only 2.9% annually, creating significant downside risk if growth disappoints or margins compress [Yahoo Finance].

1 of 4 risks in this report

Risks

4

Opportunities

5

Red flags

2

Leadership

10

10 more findings in the full report — free with any account.

Unlock the full Corteva Inc analysis

Create a free account to access the complete AI-generated report with inline citations.

  • 4 risks, 5 opportunities and 2 red flags — each with its source
  • 100+ financial metrics with charts and benchmarks
  • Full news summaries with source links
  • Executive team and compensation details
  • PDF export for offline use
Unlock all 11 findings3 free reports · No credit card

III · Related

You might also read

Same sector · Basic Materials — or comparable health

Want this for your watchlist?

Read three companies free. No card.

Get 3 free reports

Produced 20 May 2026, 19:55 UTC

Figures come from company filings and market data. The Sentinellis health score and the wording attached to it are our interpretation of those figures, not numbers the company reported.

Not investment advice and not a recommendation to buy or sell. Sentinellis holds no positions in the companies it covers, takes no payment from issuers, and has no broker referral arrangements.

How every figure and score is calculated